APA (7th ed.) Citation

Helbig, G., Bober, G., Seweryn, M., Wichary, R., Tukiendorf, A., Sedlak, L., . . . Kyrcz-Krzemien, S. (2015). OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE. PAGEPress Publications.

Chicago Style (17th ed.) Citation

Helbig, Grzegorz, Grazyna Bober, Marek Seweryn, Ryszard Wichary, Andrzej Tukiendorf, Lech Sedlak, Tomasz Oleksy, and Slawomira Kyrcz-Krzemien. OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE. PAGEPress Publications, 2015.

MLA (9th ed.) Citation

Helbig, Grzegorz, et al. OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE. PAGEPress Publications, 2015.